Literature DB >> 3136244

Evidence that mesolimbic dopaminergic activation underlies the locomotor stimulant action of nicotine in rats.

P B Clarke1, D S Fu, A Jakubovic, H C Fibiger.   

Abstract

L-Nicotine stimulates locomotor activity in rats which have had prior experience of the drug. The present study investigated whether this behavioral effect is related to activation of the mesolimbic dopamine system. In the first experiment, l-nicotine (0.2-0.8 mg/kg s.c.) stimulated locomotor activity and increased dopamine utilization in the olfactory tubercle, as judged by the ratio of the concentration of dihydroxyphenylacetic acid to dopamine. In other experiments, l-nicotine (0.1-0.4 mg/kg) stimulated locomotor activity in a dose-related, stereoselective manner; after pretreatment with the l-aromatic amino acid decarboxylase inhibitor NSD-1015, l-nicotine increased 3,4-dihydroxyphenylalanine/dopamine ratios in olfactory tubercle and nucleus accumbens, suggesting increased dopamine utilization, although absolute concentrations of 3,4-dihydroxyphenylalanine and dopamine were in general not significantly altered. This neurochemical action of l-nicotine was dose-dependent, stereoselective and absent in the caudate-putamen at the doses tested. l-Nicotine did not alter indices of 5-hydroxytryptamine utilization. The locomotor stimulant effect of l-nicotine was abolished by bilateral intra-accumbens microinjection of 6-hydroxydopamine, which depleted markedly mesolimbic terminal areas of dopamine. Thus, in rats which have been chronically treated with l-nicotine, a selective activation of mesolimbic dopamine appears to mediate the locomotor stimulant effect of this drug.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3136244

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  54 in total

1.  Preexposure to amphetamine and nicotine predisposes rats to self-administer a low dose of cocaine.

Authors:  B A Horger; M K Giles; S Schenk
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

2.  The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine.

Authors:  W A Corrigall; K B Franklin; K M Coen; P B Clarke
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

3.  Selective dopamine antagonists reduce nicotine self-administration.

Authors:  W A Corrigall; K M Coen
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

4.  Effects of subunit selective nACh receptors on operant ethanol self-administration and relapse-like ethanol-drinking behavior.

Authors:  Alexander Kuzmin; Elisabet Jerlhag; Sture Liljequist; Jörgen Engel
Journal:  Psychopharmacology (Berl)       Date:  2008-11-06       Impact factor: 4.530

5.  Influence of tetrodotoxin and calcium on changes in extracellular dopamine levels evoked by systemic nicotine.

Authors:  M E Benwell; D J Balfour; H M Lucchi
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

6.  Caffeine and nicotine improve visual tracking by rats: a comparison with amphetamine, cocaine and apomorphine.

Authors:  J L Evenden; M Turpin; L Oliver; C Jennings
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

7.  Behavioural and neurochemical adaptations to nicotine in rats: influence of NMDA antagonists.

Authors:  M Shoaib; M E Benwell; M T Akbar; I P Stolerman; D J Balfour
Journal:  Br J Pharmacol       Date:  1994-04       Impact factor: 8.739

8.  Nicotine increases alcohol self-administration and reinstates alcohol seeking in rats.

Authors:  A D Lê; A Wang; S Harding; W Juzytsch; Y Shaham
Journal:  Psychopharmacology (Berl)       Date:  2003-01-21       Impact factor: 4.530

9.  Neurochemical and behavioural interactions between ibogaine and nicotine in the rat.

Authors:  M E Benwell; P E Holtom; R J Moran; D J Balfour
Journal:  Br J Pharmacol       Date:  1996-02       Impact factor: 8.739

10.  Locomotor activation and dopamine release produced by nicotine and isoarecolone in rats.

Authors:  P Whiteaker; H S Garcha; S Wonnacott; I P Stolerman
Journal:  Br J Pharmacol       Date:  1995-10       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.